Intravenous Immunoglobulin and Prednisolone for RPL After ART.

NCT04701034 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Aalborg University Hospital

Collaborators